Selbyville, DE -- (SBWIRE) -- 05/01/2019 -- The worldwide market for Traveler's Diarrhea Therapeutics is expected to grow at a CAGR of roughly 7.1% over the next five years, will reach 890 million US$ in 2024, from 630 million US$ in 2019, according to a new research report.

Traveler's diarrhea (TD) is a stomach and intestinal infection. TD is defined as the passage of unformed stool (one or more by some definitions, three or more by others) while traveling. It may be accompanied by abdominal cramps, nausea, fever, and bloating. Occasionally bloody diarrhea may occur. Most travelers recover within four days with little or no treatment. About 10% of people may have symptoms for a week.

Request a sample of this premium report at: https://www.marketstudyreport.com/request-a-sample/1500956/?utm_source=releasewire.com-SP

Traveler's diarrhea is the leading cause of illness among international travelers to developing countries. Enterotoxigenic Escherichia coli (ETEC) bacteria are the primary cause of this disease. Among the estimated 65 million travelers from industrialized countries to high-risk areas in the developing world, as many as 50% may experience at least one TD episode during their journey. ETEC is usually responsible for 22-60% of all TD cases in both civilian and military groups or about 7-18 million cases per year. ETEC is also a major cause of diarrheal disease in children living in countries endemic for ETEC, leading to over 400 million diarrheal episodes and approximately 300,000 deaths each year.

The classification of Traveler's Diarrhea Therapeutics includes Immunization, Non-antibiotic Agents, Antibiotics, Anti-Motility Agents, Other. And the proportion of Non-antibiotic Agents in 2017 is about 36%, and And the proportion of Anti-Motility Agents in 2017 is about 20%.

Scope of the Report:
This report focuses on the Traveler's Diarrhea Therapeutics Market, especially in North America, Europe, Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, types and applications.

Traveler's Diarrhea Therapeutics Market Segment by Top Manufacturers Including:
- Salix Pharmaceuticals
- P&G
- Johnson & Johnson
- Otsuka Pharma
- Valneva
- Shanghai United Cell
- PaxVax
- Livzon
- Immuron

Traveler's Diarrhea Therapeutics Market Segment by Regions, regional analysis covers:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Traveler's Diarrhea Therapeutics Market Segment by Type covers
- Immunization
- Non-antibiotic Agents
- Antibiotics
- Anti-Motility Agents
- Other

Market Segment by Applications can be divided into:
- Adult Traveler's Diarrhea
- Children Traveler's Diarrhea

Request a discount on standard prices of this premium report at: https://www.marketstudyreport.com/check-for-discount/1500956/?utm_source=releasewire.com-SP

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Traveler's Diarrhea Therapeutics product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top manufacturers of Traveler's Diarrhea Therapeutics, with price, sales, revenue and global market share of Traveler's Diarrhea Therapeutics in 2017 and 2018.

Chapter 3, the Traveler's Diarrhea Therapeutics competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Traveler's Diarrhea Therapeutics breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.

Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.

Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.

Chapter 12, Traveler's Diarrhea Therapeutics market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.

Chapter 13, 14 and 15, to describe Traveler's Diarrhea Therapeutics sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Table of Contents:

3 Global Traveler's Diarrhea Therapeutics Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Traveler's Diarrhea Therapeutics Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Traveler's Diarrhea Therapeutics Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Traveler's Diarrhea Therapeutics Manufacturer Market Share in 2018
3.3.2 Top 6 Traveler's Diarrhea Therapeutics Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Traveler's Diarrhea Therapeutics Market Analysis by Regions
4.1 Global Traveler's Diarrhea Therapeutics Sales, Revenue and Market Share by Regions
4.1.1 Global Traveler's Diarrhea Therapeutics Sales and Market Share by Regions (2014-2019)
4.1.2 Global Traveler's Diarrhea Therapeutics Revenue and Market Share by Regions (2014-2019)
4.2 North America Traveler's Diarrhea Therapeutics Sales and Growth Rate (2014-2019)
4.3 Europe Traveler's Diarrhea Therapeutics Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Traveler's Diarrhea Therapeutics Sales and Growth Rate (2014-2019)
4.5 South America Traveler's Diarrhea Therapeutics Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Traveler's Diarrhea Therapeutics Sales and Growth Rate (2014-2019)
5 North America Traveler's Diarrhea Therapeutics by Country
5.1 North America Traveler's Diarrhea Therapeutics Sales, Revenue and Market Share by Country
5.1.1 North America Traveler's Diarrhea Therapeutics Sales and Market Share by Country (2014-2019)
5.1.2 North America Traveler's Diarrhea Therapeutics Revenue and Market Share by Country (2014-2019)
5.2 United States Traveler's Diarrhea Therapeutics Sales and Growth Rate (2014-2019)
5.3 Canada Traveler's Diarrhea Therapeutics Sales and Growth Rate (2014-2019)
5.4 Mexico Traveler's Diarrhea Therapeutics Sales and Growth Rate (2014-2019)

Price of Report: $3480 (Single User License) Purchase Complete Report at: https://www.marketstudyreport.com/securecheckout/paymenta/1500956?msfpaycode=sumsf/?utm_source=releasewire.com-SP

Related Report:

Asia-Pacific Traveler's Diarrhea Therapeutics Market Report 2018

In this report, the Asia-Pacific Traveler's Diarrhea Therapeutics market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

https://www.marketstudyreport.com/reports/asia-pacific-traveler-s-diarrhea-therapeutics-market-report-2018?utm_source=releasewire.com-SP

About Market Study Report
Market study report LLC allows you to manage and control all corporate research purchases to consolidate billing and vendor management. You can eliminate duplicate purchases and customize your content and license management.

Contact Us:
Market Study Report LLC
4 North Main Street,
Selbyville, Delaware 19975
USA
Phone: 1-302-273-0910
US Toll Free: 1-866-764-2150
Email: sales@marketstudyreport.com
Website: https://www.marketstudyreport.com
Blog: https://www.marketstudyreport.com/blog/